ABREVA - 0135-0200-04 - (docosanol)

Alphabetical Index


Drug Information of ABREVA

Product NDC: 0135-0200
Proprietary Name: ABREVA
Non Proprietary Name: docosanol
Active Ingredient(s): 100    mg/g & nbsp;   docosanol
Administration Route(s): TOPICAL
Dosage Form(s): CREAM
Coding System: National Drug Codes(NDC)

Labeler Information of ABREVA

Product NDC: 0135-0200
Labeler Name: GlaxoSmithKline Consumer Healthcare LP
Product Type: HUMAN OTC DRUG
FDA Application Number: NDA020941
Marketing Category: NDA
Start Marketing Date: 20100319

Package Information of ABREVA

Package NDC: 0135-0200-04
Package Description: 2 TUBE in 1 PACKAGE (0135-0200-04) > 2 g in 1 TUBE

NDC Information of ABREVA

NDC Code 0135-0200-04
Proprietary Name ABREVA
Package Description 2 TUBE in 1 PACKAGE (0135-0200-04) > 2 g in 1 TUBE
Product NDC 0135-0200
Product Type Name HUMAN OTC DRUG
Non Proprietary Name docosanol
Dosage Form Name CREAM
Route Name TOPICAL
Start Marketing Date 20100319
Marketing Category Name NDA
Labeler Name GlaxoSmithKline Consumer Healthcare LP
Substance Name DOCOSANOL
Strength Number 100
Strength Unit mg/g
Pharmaceutical Classes

Complete Information of ABREVA


General Information